| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN 81 MG | 40 |
| 1 | ASPIRIN | 39 |
| 2 | ASPIRIN 325 MG | 39 |
| 3 | LEVOTHYROXINE SODIUM | 34 |
| 4 | TERIPARATIDE | 31 |
| 5 | ORLISTAT | 30 |
| 6 | OMEPRAZOLE MAGNESIUM | 26 |
| 7 | SIMVASTATIN | 26 |
| 8 | ATORVASTATIN CALCIUM | 25 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYCODONE AND ASPIRIN | 1 | 0.0196 |
| 1 | PECTIN | 1 | 0.0125 |
| 2 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 3 | CEFOTETAN | 1 | 0.0075 |
| 4 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 5 | LIDOCAINE HCL 3% | 2 | 0.0044 |
| 6 | ACETAMINOPHEN, IBUPROFEN | 1 | 0.0027 |
| 7 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 8 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 9 | PALIFERMIN | 1 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 81 |
| 1 | Benzodiazepine [EPC] | 51 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 43 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 37 |
| 4 | Corticosteroid [EPC] | 33 |
| 5 | Parathyroid Hormone Analog [EPC] | 31 |
| 6 | Intestinal Lipase Inhibitor [EPC] | 30 |
| 7 | Atypical Antipsychotic [EPC] | 29 |
| 8 | Loop Diuretic [EPC] | 25 |
| 9 | Proton Pump Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Calcitonin [EPC] | 4 | 0.0013 |
| 2 | Intestinal Lipase Inhibitor [EPC] | 30 | 0.0013 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 4 | Potassium-sparing Diuretic [EPC] | 5 | 0.0004 |
| 5 | Prostaglandin E1 Analog [EPC] | 5 | 0.0003 |
| 6 | Parathyroid Hormone Analog [EPC] | 31 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 8 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 9 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |